Find research, discussions, posts, companies, and topics.

Aurora Cannabis (ACB): the medical-cannabis turnaround trying to outrun dilution

Aurora is trying to leave the worst cannabis-stock habits behind: Q3 FY2026 medical cannabis revenue set a record, management is exiting weaker Canadian consumer lanes, and the balance sheet has cash. The catch is that IFRS losses, Bevo restructuring, internal